SPOKANE, Wash., Aug. 30, 2018 /PRNewswire/ -- MedTech Outlook publishes an annual listing of the Top 10 companies that are at the forefront of solving oncology challenges through technology.
"We are excited to be recognized in this annual listing," says Gestalt's COO & CSO, Lisa-Jean Clifford. "Our goal is to provide digital pathology solutions that transform healthcare - from testing through treatment. We focus on having a major impact on improvements in workflow, efficiency, patient safety, quality, and cost. Our belief is that by delivering products with these goals in mind, we will have a significant impact on operations within the healthcare facility, for the pathologist and the clinician, ultimately providing faster, more accurate diagnosis and treatment for the patient."
Gestalt Diagnostics has proven expertise. Our PathFlow solution is built upon the foundation of a widely adopted radiology workflow system. We have significant success in deploying and supporting that platform. We have taken the basis of that proven technology and reworked it for the pathology lab.
"This recognition affirms our value as a leader in digital pathology. We see the opportunity to improve patient care and pathologist satisfaction using our innovative software to enable sharing of patient data with other expert clinicians by digitally freeing pathologists to work anywhere without glass slides and microscopes. Cancer treatment options today leverage biomarkers and clinical trials to tailor treatment options for patients. Helping speed this process while increasing the safety for patients is very rewarding," says Gestalt CEO, Dan Roark.
Gestalt's solution is for all laboratories from small independent facilities to large integrated delivery networks. We include a universal digital viewer that allows images from different scanners to be read in a single viewer. We have coupled this with image acquisition capability that captures and transfers large digital files. Whether you work locally or globally – our platform provides solid technical capabilities to bring your organization seamlessly and expeditiously into the digital age of healthcare.
We are a private software company offering PathFlow, our software platform specifically designed to bring the benefits of digital workflow to pathologists and laboratories. Originally developed by Gestalt's team, to support a fully digital platform for radiology which is in use in leading hospitals across the US, supporting over 13 million studies annually. Gestalt has expanded and redesigned this proven, robust solution for the laboratory space – engineered for the unique needs and workflow of pathologists.
SOURCE Gestalt Diagnostics